Genomics Sample Articles & Analysis: Older
8 news found
The GARNER Study is the largest HR-NMIBC real-world patient cohort ever assembled with both clinical and genomic detail and the first study of the broader GARNER Bladder Cancer Program. ...
CytoRecovery, Inc., a leader in the marker free enrichment, sorting, and recovery of live cells, presented recent study results at the American Association for Cancer Research (AACR) Annual Meeting 2022 currently being held in New Orleans. The study was completed in collaboration with The Laboratory of Integrative Cancer Immunology, National Cancer Institute (NCI/NIH Bethesda, MD) and Virginia ...
GRIDSS/PURPLE/LINX Workflow, used for somatic genomic rearrangement detection and classification on WGS data. This workflow takes a pair of matched tumor/normal BAM files and produces allele-specific copy number of every base of the genome, overall sample purity and ploidy, annotated SV clusters and gene fusion predictions. Moreover, it outputs ...
Patent 10,894,990, was awarded January 19, 2021, for a “High Throughput Method For Identification and Sequencing of Unknown Microbial and Eukaryotic Genomes from Complex Mixtures.” The patent protects the bacterial identification method, utilizing the novel 16S-ITS-23S amplicon, found in Intus Biosciences flagship StrainID kits. ...
He noted that sample quality has a direct impact on the fidelity of sequencing data. ...
Agilent Technologies Inc., (NYSE: A) today introduced SurePrint G3 CGH+SNP cancer catalog microarrays, addressing the growing need of researchers to detect both copy number and copy-neutral aberrations in cancer tissue samples in the same experiment. The new microarray release is accompanied by the release of Agilent CytoGenomics 2.0 software, which now includes support for ...
"We tested it on our ENU-mutagenized mouse genome, in which one ENU-induced mutation was induced approximately every 1Mb. ...
We never really knew for sure. The complete genome introduced today holds the answers to many of these questions. ...